Alliance Pharma (LON:APH) Posts Quarterly Earnings Results

Alliance Pharma (LON:APH) announced its earnings results on Tuesday. The company reported GBX 4.32 ($0.06) earnings per share for the quarter, Digital Look Earnings reports. Alliance Pharma had a negative net margin of 18.34% and a negative return on equity of 15.24%.

Alliance Pharma Stock Up 0.0 %

Shares of APH stock traded up GBX 0.01 ($0.00) during midday trading on Thursday, reaching GBX 64.21 ($0.82). 481,041 shares of the stock were exchanged, compared to its average volume of 6,047,132. Alliance Pharma has a 1 year low of GBX 24.55 ($0.31) and a 1 year high of GBX 66.20 ($0.85). The company’s 50 day moving average is GBX 62.81 and its two-hundred day moving average is GBX 53.18. The firm has a market cap of £347.66 million, a PE ratio of -10.35, a price-to-earnings-growth ratio of 1.04 and a beta of 0.67. The company has a current ratio of 2.93, a quick ratio of 1.42 and a debt-to-equity ratio of 46.27.

Wall Street Analysts Forecast Growth

Separately, Berenberg Bank lowered shares of Alliance Pharma to a “hold” rating and reduced their price objective for the company from GBX 7,000 ($89.45) to GBX 6,250 ($79.86) in a research report on Wednesday, January 29th.

Alliance Pharma Company Profile

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.